DIFLUPREDNATE for Posterior capsule opacification: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 157 adverse event reports in the FDA FAERS database where DIFLUPREDNATE was used for Posterior capsule opacification.
Most Reported Side Effects for DIFLUPREDNATE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Intraocular pressure increased | 478 | 28.4% | 0 | 4 |
| Drug ineffective | 139 | 8.3% | 0 | 5 |
| Therapy partial responder | 100 | 6.0% | 0 | 0 |
| Vision blurred | 94 | 5.6% | 0 | 8 |
| Eye irritation | 92 | 5.5% | 0 | 3 |
| Eye pain | 87 | 5.2% | 0 | 4 |
| Visual impairment | 84 | 5.0% | 0 | 3 |
| Treatment failure | 58 | 3.5% | 0 | 0 |
| Blindness | 49 | 2.9% | 0 | 3 |
| Cataract | 48 | 2.9% | 0 | 10 |
| Eye inflammation | 46 | 2.7% | 0 | 1 |
| No adverse event | 44 | 2.6% | 0 | 0 |
| Headache | 40 | 2.4% | 1 | 6 |
| Product availability issue | 40 | 2.4% | 0 | 3 |
| Glaucoma | 35 | 2.1% | 0 | 1 |
Other Indications for DIFLUPREDNATE
Product used for unknown indication (1,028)
Postoperative care (110)
Cataract operation (58)
Uveitis (35)
Eye inflammation (29)
Iritis (17)
Inflammation (14)
Preoperative care (12)
Glaucoma (10)
Corneal transplant (7)